A study of patients infected with acute hepatitis C virus (HCV) infection found that women had higher rates of spontaneous viral clearanceundetectable levels of the virus without initiating drug therapy. Findings published in Hepatology, a journal of the American Association for the Study of Liver Diseases, indicate that the gene IL28B (rs12979860) and HCV genotype 1 are also independent predictors of spontaneous HCV clearance.
In 2011, there were 1,229 cases of acute HCV reported to the Centers for Disease Control and Infection (CDC), which represents a 44 percent increase over 2010. Medical evidence indicates that 25 percent of those with acute HCV spontaneously clear their infection. Previous prospective studies link female sex, immune responses, neutralizing antibodies and genetics to viral clearance.
Knowledge of acute HCV clearance is limited given that patients are typically asymptomatic during the initial stages of infection and at-risk populations, such as people who inject drugs, are often marginalized, explains lead author Dr. Jason Grebely at The Kirby Institute, University of New South Wales in Australia. Our research aims to advance understanding of time to and predictors of HCV clearance to improve early therapeutic intervention options.
Researchers used data from the InC3 Studya collaboration of nine prospective studies from Australia, Canada, the Netherlands, and the U.S. funded by the National Institutes of Health and led by professor Kimberly Page from the University of California San Franciscowhich included participants with HCV and human immunodeficiency virus (HIV) who were recruited between 1985 and 2010. The present study included 632 individuals diagnosed with acute HCV with 35 percent of the group being female and 82 percent Caucasian. Roughly 96 percent of participants had injected drugs, 47 percent were infected with HCV genotype 1 and 5 percent were co-infected with HIV.
Results show that 173 of the 632 participants had spontaneously cleared the virus during follow-up. At one year post-infection, 25 percent had HCV clearance. The average time to clearance among those who cleared HCV was 16.5 weeks, with 34 percent, 67 percent and 83 percent demonstrating clearance at 3, 6 and 12 months, respectively.
Our findings indicate that females, those with the IL28B gene, and those with HCV genotype 1 are independent predictors of spontaneous clearance of acute HCV, says Page. Further research is necessary to understand the effect of sex in controlling HCV infection.
Reference: Grebely J, et al. The Effects of Female Sex, Viral Genotype and Il28b Genotype on Spontaneous Clearance of Acute Hepatitis C Virus Infection. Hepatology; (DOI: 10.1002/hep.26639); Published Online: August 2, 2013.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.